Cytomegalovirus

"C.M.V."

Now that protease inhibitors are combating HIV to the point that PWAs are living longer, one doctor at a recent conference noted that managing HIV Disease has become managing CMV more than anything else. CMV is very common in those with low t-cell counts -- less than 100.

This is part of a series on Opportunistic Infections ("OIs"). Please note that --

  1. This Page Is Just A Starting Point: ÆGIS is a great place for you to find overview information about HIV and opportunistic infections, but it is not a substitute for getting medical advice from a doctor who specializes in treating HIV.
  2. Finding The Latest Information: Advances in treating opportunistic infections can happen at any time, so the material on this page may be outdated. Some links in the see also section at the bottom of this page are actually special database links. They may contain information published after this page was written.

Classification

herpes-type virus (cytomegalovirus)

Description


Danger Zone

NOTES: Protease inhibitors: There is a study indicating taking a protease inhibitor may make you more likely to get CMV Retinitis, even at higher t-cell levels. [details]

CD4 count: If you are undergoing treatment that has increased your CD4+ levels, see the important note on Naive T-Cells. There is some evidence that you should use the lowest CD4+ level you ever had when considering your risk for some opportunistic infections.


Prevention


Treatment


See Also...


This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1998-2006. AEGiS.